101 related articles for article (PubMed ID: 28645514)
1. Bcl-x
Beaumatin F; El Dhaybi M; Bobo C; Verdier M; Priault M
Biochim Biophys Acta Mol Cell Res; 2017 Oct; 1864(10):1734-1745. PubMed ID: 28645514
[TBL] [Abstract][Full Text] [Related]
2. N52 monodeamidated Bcl‑xL shows impaired oncogenic properties in vivo and in vitro.
Beaumatin F; El Dhaybi M; Lasserre JP; Salin B; Moyer MP; Verdier M; Manon S; Priault M
Oncotarget; 2016 Mar; 7(13):17129-43. PubMed ID: 26958941
[TBL] [Abstract][Full Text] [Related]
3. Impact of Deamidation on the Structure and Function of Antiapoptotic Bcl-x
Tanriver G; Monard G; Catak S
J Chem Inf Model; 2022 Jan; 62(1):102-115. PubMed ID: 34942070
[TBL] [Abstract][Full Text] [Related]
4. Bcl-x
Dho SH; Manson SR; Jung SH; Lim JC; Weintraub SJ
Biochim Biophys Acta Mol Cell Res; 2018 Jul; 1865(7):995-1001. PubMed ID: 29694915
[TBL] [Abstract][Full Text] [Related]
5. Improved Electrophoretic Separation to Assist the Monitoring of Bcl-xL Post-Translational Modifications.
Bobo C; Céré C; Dufossée M; Dautant A; Moreau V; Manon S; Beaumatin F; Priault M
Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31717257
[TBL] [Abstract][Full Text] [Related]
6. DNA damage-induced Bcl-xL deamidation is mediated by NHE-1 antiport regulated intracellular pH.
Zhao R; Oxley D; Smith TS; Follows GA; Green AR; Alexander DR
PLoS Biol; 2007 Jan; 5(1):e1. PubMed ID: 17177603
[TBL] [Abstract][Full Text] [Related]
7. Suppression of Bcl-xL deamidation in human hepatocellular carcinomas.
Takehara T; Takahashi H
Cancer Res; 2003 Jun; 63(12):3054-7. PubMed ID: 12810626
[TBL] [Abstract][Full Text] [Related]
8. Corrigendum to "Bcl xL deamidation and cancer: Charting the fame trajectories of legitimate child and hidden siblings." [Biochim. Biophys. Acta 1864/10 (2017) 1734-1745].
Beaumatin F; El Dhaybi M; Bobo C; Verdier M; Priault M
Biochim Biophys Acta Mol Cell Res; 2018 Mar; 1865(3):542-543. PubMed ID: 29329791
[No Abstract] [Full Text] [Related]
9. Bcl-xL is an oncogenic driver in colorectal cancer.
Scherr AL; Gdynia G; Salou M; Radhakrishnan P; Duglova K; Heller A; Keim S; Kautz N; Jassowicz A; Elssner C; He YW; Jaeger D; Heikenwalder M; Schneider M; Weber A; Roth W; Schulze-Bergkamen H; Koehler BC
Cell Death Dis; 2016 Aug; 7(8):e2342. PubMed ID: 27537525
[TBL] [Abstract][Full Text] [Related]
10. AT-101 simultaneously triggers apoptosis and a cytoprotective type of autophagy irrespective of expression levels and the subcellular localization of Bcl-xL and Bcl-2 in MCF7 cells.
Antonietti P; Gessler F; Düssmann H; Reimertz C; Mittelbronn M; Prehn JH; Kögel D
Biochim Biophys Acta; 2016 Apr; 1863(4):499-509. PubMed ID: 26721623
[TBL] [Abstract][Full Text] [Related]
11. Functional and biological analysis of Bcl-xL expression in human osteosarcoma.
Wang ZX; Yang JS; Pan X; Wang JR; Li J; Yin YM; De W
Bone; 2010 Aug; 47(2):445-54. PubMed ID: 20580954
[TBL] [Abstract][Full Text] [Related]
12. The association of deamidation of Bcl-xL and translocation of Bax to the mitochondria through activation of JNK in the induction of apoptosis by treatment with GSH-conjugated DXR.
Asakura T; Maeda K; Omi H; Matsudaira H; Ohkawa K
Int J Oncol; 2008 Aug; 33(2):389-95. PubMed ID: 18636161
[TBL] [Abstract][Full Text] [Related]
13. Bcl-xL is overexpressed in hormone-resistant prostate cancer and promotes survival of LNCaP cells via interaction with proapoptotic Bak.
Castilla C; Congregado B; Chinchón D; Torrubia FJ; Japón MA; Sáez C
Endocrinology; 2006 Oct; 147(10):4960-7. PubMed ID: 16794010
[TBL] [Abstract][Full Text] [Related]
14. Bcl-X
Li M; Wang D; He J; Chen L; Li H
Pharmacol Res; 2020 Jan; 151():104547. PubMed ID: 31734345
[TBL] [Abstract][Full Text] [Related]
15. Bcl-xL is phosphorylated in malignant cells following microtubule disruption.
Poruchynsky MS; Wang EE; Rudin CM; Blagosklonny MV; Fojo T
Cancer Res; 1998 Aug; 58(15):3331-8. PubMed ID: 9699663
[TBL] [Abstract][Full Text] [Related]
16. Structural insights into mouse anti-apoptotic Bcl-xl reveal affinity for Beclin 1 and gossypol.
Priyadarshi A; Roy A; Kim KS; Kim EE; Hwang KY
Biochem Biophys Res Commun; 2010 Apr; 394(3):515-21. PubMed ID: 20206602
[TBL] [Abstract][Full Text] [Related]
17. Differential effect of anti-apoptotic genes Bcl-xL and c-FLIP on sensitivity of MCF-7 breast cancer cells to paclitaxel and docetaxel.
Wang Z; Goulet R; Stanton KJ; Sadaria M; Nakshatri H
Anticancer Res; 2005; 25(3c):2367-79. PubMed ID: 16080463
[TBL] [Abstract][Full Text] [Related]
18. Control of cellular Bcl-xL levels by deamidation-regulated degradation.
Dho SH; Deverman BE; Lapid C; Manson SR; Gan L; Riehm JJ; Aurora R; Kwon KS; Weintraub SJ
PLoS Biol; 2013; 11(6):e1001588. PubMed ID: 23823868
[TBL] [Abstract][Full Text] [Related]
19. [Overcoming acquired resistance to tumor necrosis factor-related apoptosis-inducing ligand by Bcl-XL small interfering RNA in human colon cancer].
Zhu HB; Huang XF; Hu JZ; Zhou W; Chen W; Chen LL; He C
Zhonghua Zhong Liu Za Zhi; 2008 Apr; 30(4):245-9. PubMed ID: 18788624
[TBL] [Abstract][Full Text] [Related]
20. Let-7b binding site polymorphism in the B-cell lymphoma-extra large 3'UTR is associated with fluorouracil resistance of hepatocellular carcinoma.
Ma J; Guo R; Wang T; Pan X; Lei X
Mol Med Rep; 2015 Jan; 11(1):677-81. PubMed ID: 25333670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
